Correlation Between Tonix Pharmaceuticals and Eyenovia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Eyenovia, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Eyenovia.

Diversification Opportunities for Tonix Pharmaceuticals and Eyenovia

TonixEyenoviaDiversified AwayTonixEyenoviaDiversified Away100%
0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tonix and Eyenovia is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Eyenovia go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Eyenovia

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Eyenovia. In addition to that, Tonix Pharmaceuticals is 2.11 times more volatile than Eyenovia. It trades about -0.44 of its total potential returns per unit of risk. Eyenovia is currently generating about -0.35 per unit of volatility. If you would invest  298.00  in Eyenovia on November 30, 2024 and sell it today you would lose (129.00) from holding Eyenovia or give up 43.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  Eyenovia

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50050100150200
JavaScript chart by amCharts 3.21.15TNXP EYEN
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb10203040506070
Eyenovia 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb24681012141618

Tonix Pharmaceuticals and Eyenovia Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-65.73-49.23-32.73-16.230.016.4333.1349.8466.54 0.00100.00150.00200.00250.0030
JavaScript chart by amCharts 3.21.15TNXP EYEN
       Returns  

Pair Trading with Tonix Pharmaceuticals and Eyenovia

The main advantage of trading using opposite Tonix Pharmaceuticals and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.
The idea behind Tonix Pharmaceuticals Holding and Eyenovia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.